SØR PHARMA INVEST AS

Signals

1 flags

• ▼ Driftsunderskudd 2024 Siste driftsresultat er negativt (−30k kr).

SØR PHARMA INVEST AS is registered as a limited company in Arendal, Agder with organisation number 924554037. The business is classified under uoppgitt (NACE 00.000). The company was incorporated in 2020. Registered share capital is NOK 30,000, divided into 30000 shares. The company's stated purpose is: “Eie aksjer samt investering og forvaltning av aksjer.”. The most recent filed accounts, for the 2024 financial year, show NOK 0 in revenue and NOK −30,000 in operating profit.

Key figures · 2024

Revenue

NOK 0

Operating profit

NOK −30,000

Equity

NOK 2.5m

Est. value

NOK 4.5m

Financial health · 2024

Liquidity

1183.31

Very good

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

99.9%

Very good

Equity as a share of total capital

Who owns SØR PHARMA INVEST AS?

MOHAMAD KAROUNI

100.0%

SØR PHARMA INVEST AS

NOK 0 rev. · NOK −30,000 profit

SØR PHARMA INVEST AS has 1 registered shareholder:

• MOHAMAD KAROUNI 100.0%

All shareholders and roles →

Which companies does SØR PHARMA INVEST AS own?

SØR PHARMA INVEST AS holds stakes in 4 companies:

• NEDENES APOTEK AS 51.0%
• APOTEK 1 STOA VEST AS 50.0%
• STOA APOTEK AS 25.0%
• APOTEK 1 SALTRØD AS 24.5%

See the full ownership structure →

Frequently asked questions about SØR PHARMA INVEST AS

Who owns SØR PHARMA INVEST AS?

MOHAMAD KAROUNI is the largest registered owner, with 100.0%.

What is the revenue of SØR PHARMA INVEST AS?

SØR PHARMA INVEST AS had revenue of NOK 0 in 2024.

Who is the general manager of SØR PHARMA INVEST AS?

Mohamad Karouni is registered as general manager of SØR PHARMA INVEST AS.

Where is SØR PHARMA INVEST AS based?

SØR PHARMA INVEST AS has its business address in Arendal.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.